| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 29, 2026 | Sell(S) | 11K | $108.28 | $1.2M | 2.4M |
| Jun 29, 2026 | Sell(S) | 8K | $109.75 | $860K | 2.4M |
| Jun 29, 2026 | Sell(S) | 8K | $110.67 | $841K | 2.4M |
| Jun 29, 2026 | Sell(S) | 907 | $111.20 | $101K | 2.4M |
| Jun 29, 2026 | Sell(S) | 2K | $108.28 | $183K | 464K |
| Jun 29, 2026 | Sell(S) | 1K | $109.75 | $136K | 463K |
| Jun 29, 2026 | Sell(S) | 1K | $110.67 | $133K | 462K |
| Jun 29, 2026 | Sell(S) | 157 | $111.20 | $17K | 462K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001451612-26-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Kymera Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001451612-26-000020"
Use Arkolith to summarize insider buying and selling at Kymera Therapeutics, Inc. over the last 90 days and cite the filings.